You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CapeOX

Showing 1 - 25 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2 Gene Mutation Trial (Injection of IAH0968 + CAPEOX, PLACEBO+CAPEOX)

Not yet recruiting
  • HER2 Gene Mutation
  • Injection of IAH0968 + CAPEOX
  • PLACEBO+CAPEOX
  • (no location specified)
Jan 4, 2023

Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

Recruiting
  • Colon Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 26, 2023

Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • Tianjin, Tianjin, China
    Xuewei Ding
Aug 2, 2023

Stomach Tumor Trial in Chengdu (Capeox regimen combined with Sintilimab and Bevacizumab)

Not yet recruiting
  • Stomach Neoplasm
  • Capeox regimen combined with Sintilimab and Bevacizumab
  • Chengdu, China
    Liu Ming
Nov 28, 2022

Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)

Not yet recruiting
  • Rectal Cancer
  • Locally Advanced
  • Short-course radiotherapy
  • +3 more
  • (no location specified)
Oct 8, 2022

Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • CapeOX + cetuximab
  • +2 more
  • (no location specified)
Sep 12, 2023

pMMR, MSS, MSI-L Trial (Serplilumab, Capecitabine, Oxaliplatin)

Not yet recruiting
  • pMMR
  • +3 more
  • (no location specified)
Feb 19, 2023

Rectal Cancer Trial in Hangzhou (Envafolimab)

Not yet recruiting
  • Rectal Cancer
  • Envafolimab
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Mar 1, 2023

Rectal Cancer Trial in Hangzhou (Envafolimab)

Recruiting
  • Rectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
May 4, 2023

Metastatic Colorectal Cancer Trial in Wuhan (SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab)

Recruiting
  • Metastatic Colorectal Cancer
  • SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab
  • Wuhan, Hubei, China
    Xianglin Yuan
Jun 24, 2022

Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +

Not yet recruiting
  • Stage I Colon Cancer
  • +2 more
  • Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
  • +2 more
  • Houston, Texas
    Baylor College of Medicine
May 22, 2023

Colorectal Cancer Trial in Shanghai, Hangzhou, Ningbo (Capecitabine tablets, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
  • +3 more
Jan 16, 2023

Locally Advanced Rectal Cancer Trial in Shijiazhuang (Tislelizumab, Short-course radiotherapy, Capecitabine+Oxaliplatin)

Recruiting
  • Locally Advanced Rectal Cancer
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 1, 2022

Rectal Cancer Trial in Shanghai (FOLFOXIRI, CapeOX)

Recruiting
  • Rectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Feb 16, 2022

Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,

Recruiting
  • Metastatic Gastric Cancer
  • +2 more
  • New York, New York
    Bureau for Cancer Research
May 10, 2023

Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)

Not yet recruiting
  • Colon Cancer
  • Immunotherapy
  • Chongqing, China
    Daping hospital
Apr 16, 2023

Colorectal Cancer Trial in Wenzhou (mFOLFOXIRI, mFOLFOX6 OR CapeOx)

Recruiting
  • Colorectal Cancer
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Jan 18, 2022

Neoadjuvant Treatment, Rectal Cancer, Anlotinib Trial (Anlotinib+Capeox, Capeox)

Withdrawn
  • Neoadjuvant Treatment
  • +2 more
  • (no location specified)
Sep 22, 2021

Chemo-induced Nausea and Vomiting Trial in Tianjin (Granisetron Transdermal Patch System)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Granisetron Transdermal Patch System
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Apr 11, 2022

Unresectable Metastatic Colorectal Cancer Trial in China (AK105 injection, Anlotinib HCl capsule, CapeOX)

Recruiting
  • Unresectable Metastatic Colorectal Cancer
  • AK105 injection
  • +3 more
  • Lanzhou, Gansu, China
  • +12 more
Oct 18, 2021

Adjuvant Treatment Trial (anlotinib+CAPEOX/SOX)

Not yet recruiting
  • Adjuvant Treatment
  • (no location specified)
Feb 15, 2023

Gastric Cancer Trial in Seoul (Pembrolizumab)

Recruiting
  • Gastric Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Dec 23, 2021

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)

Not yet recruiting
  • Colonic Neoplasms
  • Dostarlimab
  • +2 more
  • (no location specified)
May 3, 2023

Colorectal Cancer, Liver Metastases, Circulating Tumor Cell Trial in GuangZhou (Colorectal cancer resection combined with liver

Recruiting
  • Colorectal Cancer
  • +3 more
  • Colorectal cancer resection combined with liver metastasis resection.
  • FOLFOX chemotherapy regimen
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 14, 2023